BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News

Breast Cancer News Articles

Get Our Industry eNewsletter FREE email:    
 Top Breaking News
Pfizer (PFE) Beams As Cancer Drug Efficacy Stops Trial Early and Analysts Predict Game Changer     4/17/2015
Roche (RHHBY) Says 11 Late-Stage Cancer Drugs Will Enter Trials in 2015     4/15/2015
Nektar Therapeutics (NKTR) Cancer Drug Improves Survival But Misses Primary Endpoint, As Watchers Worry     3/20/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
100 Pfizer (PFE) Scientists and Their Journey to Bring Ibrance to Market     3/10/2015
Analyst: Docs Bullish On Roche (RHHBY)'s Perjeta and PD-1/PDL1, Cautious on Palbociclib and Neratinib     3/5/2015
Genentech (RHHBY)'s Breast Cancer Cocktail Buys More Than a Year of Life     2/25/2015
FDA Green Lights Pfizer (PFE)'s High Profile Breast Cancer Drug Two Months Early     2/5/2015
Roche (RHHBY) Suffers A Double Blow As Breast Cancer, Alzheimer’s Drug Studies Fail; Pulls Plug On ALZ's Drug Development     12/23/2014
Merck & Co. (MRK)'s Keytruda Shrank Tumors In Hard-To-Treat Breast Cancer Patients     12/11/2014
Analysts Not Sold On Medivation, Inc. (MDVN)’s Xtandi as Breast Cancer Drug     12/10/2014
Novartis AG (NVS) Copy Of Amgen (AMGN) Cancer Drug Shows Similar Efficacy     12/8/2014
Puma Biotechnology (PBYI) Sinks On Breast Cancer Drug NDA Delay     12/4/2014
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Merrion Pharmaceuticals, Inc. Bids To Attract €52m Investment For Products     12/1/2014
 Featured Stories
Soyfoods Reduce Breast Cancer Recurrence, University Medical Center Study     4/20/2015
Cancer Research Uncovers The Fountain Of Youth, University of Toronto Study     4/10/2015
How Artificial Light Can Mess With Your Health, University of Connecticut Researchers Say     3/20/2015
Genentech (RHHBY) Dives Into Apps to Help Cancer Patients     3/4/2015
A New Weapon In The Fight Against Cancer, Concordia University Reveals     2/20/2015
Unhealthy Insulin Levels May Boost Breast Cancer Risk, Imperial College London Study     1/16/2015
Hold Your Breath To Protect Your Heart, Thomas Jefferson University Study     1/7/2015
Low-Fat Diet May Help Women Survive Breast Cancer, UCLA Medical Center Study     12/16/2014
No Link Between Migraine, Breast Cancer Risk, Harvard University Study Says     12/15/2014
A*STAR Scientists Uncover Gene Associated With An Aggressive Breast Cancer     12/2/2014
Increasing Skirt Size Boosts Your Breast Cancer Risk, University College London Study     9/26/2014
Is Soy A Foe To Women With Breast Cancer? Memorial Sloan-Kettering Cancer Center Study     9/8/2014
Bras Cause Breast Cancer? Apparently Not, Fred Hutchinson Cancer Research Center Study     9/5/2014
Study Ties New Gene Mutation To Major Breast Cancer Risk, The New England Journal of Medicine Reveals     8/7/2014
Birth Control Pills May Double Breast Cancer Risk, Fred Hutchinson Cancer Research Center Study     8/4/2014
 More News
Case Western Reserve University Release: Breakthrough Provides New Hope For More Effective Treatments For Patients With HER2+ Breast Cancer     4/24/2015
New Data Show Rexahn Pharmaceuticals, Inc. (RNN)'s Supinoxin Decreases The Migration Of Human Triple Negative Breast Cancer Cells In A Metastatic Cancer Model     4/21/2015
Merrimack (MACK) Announces Final Clinical Results For MM-302 Phase 1 Study Demonstrating Robust Activity In Heavily Pre-Treated Patients With HER2-Positive Metastatic Breast Cancer     4/21/2015
Patients With Advanced Breast, Lung, Esophageal, And Colorectal Cancers Respond To Immunomedics, Inc. (IMMU)' Novel Antibody-Directed Chemotherapy After Failing Multiple Prior Standard Treatments     4/20/2015
OncoCyte Corporation Announces Initial Data From Ongoing Clinical Study Of Collagen Type X As A Marker And Potential Diagnostic For Breast Cancer And Other Types Of Human Cancers     4/20/2015
Avelas Biosciences Initiates Phase 1b Trial Of AVB-620 In Breast Cancer Patients     4/16/2015
Pfizer (PFE) Announces Paloma-3 Trial For Ibrance® (Palbociclib) Stopped Early Due To Efficacy Seen In Patients With Hr+, Her2- Metastatic Breast Cancer Whose Disease Has Progressed Following Endocrine Therapy     4/15/2015
Celsion Corporation (CLSN) Announces Positive Interim Data From Its Phase 2 DIGNITY Study In Breast Cancer     4/15/2015
SELLAS Life Sciences Group And Trojantec Ltd. Sign Exclusive License Agreement For Global Rights On Development And Commercialization Of Innovative TR-1 Anti-Cancer Antennapedia Technology     4/15/2015
Celldex (CLDX)' Phase 2 EMERGE Study Of Glembatumumab Vedotin In Metastatic Breast Cancer Published In Journal Of Clinical Oncology     4/7/2015
Harry Perkins Institute Of Medical Research Release: Phylogica Ltd. Peptide Fusion Kills Aggressive Breast Cancer Cells     4/7/2015
Quebec Breast Cancer Foundation Release: Breast Cancer: $4.5 Million For Nine Homegrown Researchers     4/7/2015
Pharmacyclics (PCYC) Release: Solid Tumor Study Investigating Ibrutinib (IMBRUVICA) In Combination With Anti-PD-L1 Antibody (MEDI4736) Commences In Patients With Relapsed/Refractory Non-Small Cell Lung, Breast And Pancreatic Cancers     4/1/2015
CASI Pharmaceuticals  (CASI) Announces Initiation Of A Phase 2 Trial With ENMD-2076 In Triple-Negative Breast Cancer In China     3/25/2015
Teikoku Pharma USA Announces New Drug Application To The FDA For Docetaxel Injection Concentrate, Non-Alcohol Formula     3/24/2015